Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Corso Pereira (Campinas, Brazil), S. Silva Doria (Campinas, Brazil), M. Moreira (Campinas, Brazil), P. Tonidandel (Campinas, Brazil), E. De Capitani (Campinas, Brazil), I. Paschoal (Campinas, Brazil). Bronchiectasis in COPD: increased susceptibility of the airways to aggressive agents?. 4095

Member's Comments

No comment yet.

Related content which might interest you: The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Bronchiectasis and airway eosinophilia in severe asthma—is there an association? Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Why is it important to consider (sub)phenotypes of asthma and COPD? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Influence of basic therapy of bronchial asthma (BA) on respiratory symptoms in patients with pulmonary TB associated with bronchial asthma Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019 Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016 How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy? Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use Year: 2012 Small airways targeting of inhaled steroids for severe therapy resistant asthma in children Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 Bronchial brush-biopsies cells in dependence on infectional agent species at COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Bronchial brush-biopsies cells in dependence on infectional agent species at COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Is infection screening in BAL fluid useful in children with chronic obstructive airway disease unresponsive to anti-asthmatic treatment? Source: Eur Respir J 2006; 28: Suppl. 50, 310s Year: 2006 IL-33 and airway remodelling in paediatric severe therapy resistant asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012 Treatment of combined pulmonary fibrosis and emphysema Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Lung function in patients with different infecting agents caused acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003